Withdrawal of Anticonvulsant Drugs in Patients Free of Seizures for Two Years

New England Journal of Medicine

Volumn 318, Issue 15, 1988, Pages 942-946

  Callaghan, Noel ^a   Garrett, Andrew ^b   Goggin, Timothy ^c  

^a University College Cork and INFANT Centre   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c Parke Davis and McDonnell Douglas Systems ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID;

DRUG WITHDRAWAL; EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEIZURE;

ADULT; ANALYSIS OF VARIANCE; ANTICONVULSANTS; CARBAMAZEPINE; COMPARATIVE STUDY; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; EPILEPSY; FEMALE; HUMAN; MALE; PHENYTOIN; PROGNOSIS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; VALPROIC ACID;

EID: 0023911979     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198804143181502     Document Type: Article

References (32)

1. Schmidt D. Adverse effects of antiepileptic drugs. New York: Raven Press, 1982.
2. Reynolds EH. Chronic antiepileptic toxicity: a review. Epilepsia 1975; 16: 319–52.
3. Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med 1986; 59: 569–77.
4. Reynolds EH. Adverse haematological effects of antiepileptic drugs. In: Oxley J, Janz D, Meinardi H, eds. Chronic toxicity of antiepileptic drugs. New York: Raven Press, 1983:91–9.
5. Jeavons PM. Hepatotoxicity of antiepileptic drugs. In: Oxley J, Janz D, Meinardi H, eds. Chronic toxicity of antiepileptic drugs. New York: Raven Press, 1983:1–45.
6. Stores G. Behavioural effects of anti-epileptic drugs. Dev Med Child Neurol 1975; 17: 647–58.
7. Tchicaloff M, Gaillard F. Quelques effets indesirables des medicaments anti-epileptiques sur les rendements intellectuels. Rev Neuropsychiatrie Infant Hyg Ment Enfance 1970; 18: 599–604.
8. Logan WJ, Freeman JM. Pseudodegenerative disease due to diphenylhydantoin intoxication. Arch Neurol 1969; 21: 631–7.
9. Juul-Jensen P. Frequency of recurrence after discontinuance of anti-convulsant therapy in patients with epileptic seizures: new follow-up study after 5 years. Epilepsia 1968; 9: 11–16.
10. Oller-Daurella L, Pamies R, Oller L. Reduction or discontinuance of antiepileptic drugs in patients seizure-free for more than 5 years. In: Janz D, ed. Epileptology. Littleton, Mass.: Publishing Sciences Group, 1976:218–27.
11. Holowach J, Thurston DL, O'Leary J. Prognosis of childhood epilepsy: follow-up study of 148 cases in which therapy had been suspended after prolonged anticonvulsant control. N Engl J Med 1972; 286: 169–74.
12. Emerson R, D'Souza BJ, Vining EP, Holden KR, Mellits ED, Freeman JM. Stopping medication in children with epilepsy: predictors of outcome. N Engl J Med 1981; 304: 1125–9.
13. Thurston JH, Thurston DL, Hixon BB, Keller AJ. Prognosis in childhood epilepsy: additional follow-up of 148 children 15 to 23 years after withdrawal of anticonvulsant therapy. N Engl J Med 1982; 306: 831–6.
14. Shinnar S, Vining EPG, Mellits ED, et al. Discontinuing antiepileptic medication in children with epilepsy after two years without seizures: a prospective study. N Engl J Med 1985; 313: 976–80.
15. Callaghan N, Kenny RA, O'Neill B, Crowley M, Goggin T. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry 1985; 48: 639–44.
16. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22: 489–501.
17. Anderson JA. Separate sample logistic discrimination. Biometrika 1972; 59: 19–35.
18. Hosmer DW, Lemeshaw S. Goodness of fit test for the multiple logistic regression model. Commun Stat [A] 1958; 9: 1034–69.
19. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958; 8: 699–712.
20. Van Heycop Ten Ham MW. Complete recovery from epilepsy? Huisants en Wetenshap 1980; 23: 309–11.
21. Yahr MD, Sciarra D, Carter S, Merritt HH. Evaluation of Standard anticonvulsant therapy in three hundred nineteen patients. JAMA 1952; 150: 663–7.
22. Strobos RRJ. Prognosis in convulsive disorders. Arch Neurol 1959; 1: 216–25.
23. Merritt HH. Medical treatment in epilepsy. Br Med J 1958; 1: 666–9.
24. Janz D, Sommer-Burkhardt EM. Discontinuation of antiepileptic drugs in patients with epilepsy who have been seizure-free for more than two years. In: Janz D, ed. Epileptology. Littleton, Mass.: Publishing Sciences Group, 1976:228–34.
25. Overweg J, Rowan AJ, Binnie CD, Oosting J, Nagelkerke NJD. Prediction of seizure recurrence after withdrawal of antiepileptic drugs. In: Dam M, Gram L, Penry JK, eds. Advances in epileptology: XIIth Epilepsy International Symposium. New York: Raven Press, 1981:503–8.
26. Zenker C, Groh C, Roth G. Probleme und Erfahrungen beim Abentzen anticonvulsiver Therapie. Neue Osterrich Z Kinderheilkd 1957; 2: 152–63.
27. Rodin EA, John G. Withdrawal of anticonvulsant medications in successfully treated patients with epilepsy. In: Wada JA, Penry JK, eds. Advances in epileptology: the Xth Epilepsy International Symposium. New York: Raven Press, 1980:183–6.
28. Todt H. The late prognosis of epilepsy in childhood: results of a prospective follow-up study. Epilepsia 1984; 25: 137–44.
29. O'Donoghue NV. Epilepsies of childhood. London: Butterworths, 1979:99–105.
30. Schmidt D. Withdrawal of antiepileptic drugs. In: Wolf P, Dam M, Janz D, Dreifuss F, eds. Advances in epileptology: the XVIth Epilepsy International Symposium. New York: Raven Press, 1987:373–7.
31. Chadwick D, Reynolds EH. When do epileptic patients need treatment? Starting and stopping medication. Br Med J 1985; 290: 1885–8.
32. Spencer SS, Spencer DD, Williamson PD, Mattson RH. Ictal effects of anticonvulsant medication withdrawal in epileptic patients. Epilepsia 1981; 22: 297–307.